Clinical Trials
3 results for Kidney/Renal Cancer
Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC and a Moderate to High Risk
- Condition: Renal Cell Carcinoma
- Intervention: Drug: Axitinib, Drug: Avelumab
- Study ID: NCT03341845
A Pilot Study of Neoadjuvant Combination Spartalizumab and Canakinumab Prior to Radical Nephrectomy in Patients With Localized Clear Cell Renal Cell Carcinoma (SPARC-1 Trial)
- Condition: Carcinoma, Renal Cell
- Intervention: Drug: Spartalizumab, Drug: Canakinumab
- Study ID: NCT04028245
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
- Condition: Bile Duct Cancer, Gall Bladder Cancer, Breast Cancer, Neuroendocrine Tumors, Ovarian Cancer, Pancreatic Adenocarcinoma, Soft Tissue Sarcoma, Vulvar Cancer, Prostate Cancer
- Study ID: NCT05000294